Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema

NCT02949024 is registered in ClinicalTrials.gov with Clearside Biomedical, Inc. as lead sponsor.

NCT NCT02949024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02949024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Lead sponsor
Clearside Biomedical, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
November 10, 2016
Completion date
October 17, 2017
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema